What is Augmedit?
Augmedit is at the forefront of medical software innovation, specializing in augmented reality solutions designed to enhance surgical procedures. Their core offering involves a sophisticated system capable of transforming standard 2D DICOM images into interactive 3D holograms. This technology is pivotal for improving surgical planning and providing critical intra-operative visualization for medical professionals, particularly neurosurgeons and their teams. By aiming to elevate patient outcomes and optimize surgical workflows, Augmedit offers its solutions through an accessible subscription model, ensuring compatibility with leading hardware such as the HoloLens 2.
How much funding has Augmedit raised?
Augmedit has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2022): $1M with participation from Venture Capital Fund Revere Partners
Key Investors in Augmedit
Venture Capital Fund Revere Partners
Venture Capital Fund Revere Partners is an investor in Augmedit's Angel/Seed funding round. Their involvement suggests a focus on early-stage technology companies with disruptive potential in specialized markets.
What's next for Augmedit?
The recent major strategic investment signals Augmedit's transition into a scaling phase, likely focusing on expanding its market reach and further developing its AR-assisted surgical platforms. This infusion of capital is expected to accelerate product development, bolster sales and marketing efforts, and potentially forge new strategic partnerships within the healthcare ecosystem. The company's focus on improving surgical precision and visualization positions it for substantial growth in the rapidly evolving field of medical technology.
See full Augmedit company page
